Rotavirus Infections

CDC-9 Inactivated Rotavirus Vaccine (IRV) Intramuscular (IM) Phase 1 Clinical Trial in Healthy Adults

CDC-9 Inactivated Rotavirus Vaccine (IRV) Microneedle Patch (MNP) in Healthy Adults

SaniVac Trial - Sanitation and Oral Rotavirus Vaccine Performance

Safety and Immunogenicity Study of Recombinant Trivalent Rotavirus Subunit Vaccine in Healthy Infants and Toddlers

Phase II Clinical Trial of the Inactivated Rotavirus Vaccine

A Phase II Dose-ranging Study of Oral RV3-BB Rotavirus Vaccine

A Surveillance Study on Timing and Coverage Of Rotavirus and MenB Vaccine Co-administration in Campania Region, Italy

Safety and Immunological Efficacy of the Pentavalent Rotavirus Vaccine - Rota-V-Aid™ (Live Attenuated Oral, Freeze-dried) at Healthy Adults Aged 18 to 45 Years.

Evaluation of an Infant Immunization Encouragement Program in Nigeria

Evaluate Immunogenicity, Safety, and Reactogenicity of Rotavac® in Healthy Infants Aged Between 6-8 Weeks in Vietnam

Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot Study

RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016)

The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses

To Evaluate 2 Doses of GSK Biologicals' Oral Live Attenuated Human HRV Vaccine Co-administered With Either OPV or IPV

Vaccine Effectiveness of RV1 in a Naïve Population

ROTATEQ™ Post-Marketing Surveillance in the Philippines

Consistency Lots Vaccine Study (V260-009)

Rotavirus Efficacy and Safety Trial (REST)(V260-006)

Dose Confirmation Efficacy Study (V260-007)

Concomitant Use and Staggered Use of Vaccine and Oral Poliovirus (OPV) in Healthy Infants (V260-014)(COMPLETED)